In Post-Grant Review, Board Cancels 19 Claims Of Organ Ablation Patent

Mealey's (May 10, 2018, 10:55 AM EDT) -- ALEXANDRIA, Va. — In a final written decision issued May 8, the Patent Trial and Appeal Board found that 19 claims of a method for ablating an organ are unpatentable for failure to satisfy the written description requirement of 35 U.S. Code Section 112(a) (Minerva Surgical Inc. v. Hologic Inc., No. PGR2017-00002, PTAB)....